Reviva Pharmaceuticals Holdings Stock Today
| RVPH Stock | USD 1.41 0.05 3.42% |
PerformanceModest
| Odds Of DistressAverage
|
Reviva Pharmaceuticals is trading at 1.41 as of the 26th of February 2025. This is a 3.42% down since the beginning of the trading day. The stock's open price was 1.46. Reviva Pharmaceuticals has 52 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 28th of November 2024 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 18th of October 2018 | Category Healthcare | Classification Health Care |
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company has 46.58 M outstanding shares of which 5.04 M shares are at this time shorted by private and institutional investors with about 2.16 trading days to cover. More on Reviva Pharmaceuticals Holdings
Moving against Reviva Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Reviva Stock Highlights
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsReviva Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Reviva Pharmaceuticals' financial leverage. It provides some insight into what part of Reviva Pharmaceuticals' total assets is financed by creditors.
| |||||
Reviva Pharmaceuticals Holdings (RVPH) is traded on NASDAQ Exchange in USA. It is located in 10080 N. Wolfe Road, Cupertino, CA, United States, 95014 and employs 15 people. Reviva Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 65.68 M. Reviva Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 46.58 M outstanding shares of which 5.04 M shares are at this time shorted by private and institutional investors with about 2.16 trading days to cover.
Reviva Pharmaceuticals Holdings currently holds about 23.19 M in cash with (28.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.13.
Check Reviva Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationReviva Pharmaceuticals owns a total of 46.58 Million outstanding shares. Reviva Pharmaceuticals holds significant amount of outstanding shares owned by insiders and institutional investors . Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Reviva Ownership Details
Reviva Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Group One Trading, Lp | 2024-09-30 | 75.6 K | |
| The Colony Group Llc | 2024-12-31 | 60 K | |
| H D Vest Advisory Services | 2024-12-31 | 60 K | |
| Northern Trust Corp | 2024-12-31 | 56.6 K | |
| Ameriprise Financial Inc | 2024-12-31 | 46.5 K | |
| Emc Capital Management(tx) | 2024-12-31 | 44.5 K | |
| Engineers Gate Manager Lp | 2024-12-31 | 34.6 K | |
| Sound Income Strategies | 2024-12-31 | 30 K | |
| Tower Research Capital Llc | 26.8 K | ||
| Millennium Management Llc | 2024-12-31 | 1.8 M | |
| Vanguard Group Inc | 2024-12-31 | 1.4 M |
Reviva Pharmaceuticals Historical Income Statement
Reviva Stock Against Markets
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.